LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1.
Wang B, Zhao B, Pang LP, Zhao YD, Guo Q, Wang JW, Zheng YC, Zhang XH, Liu Y, Liu GY, Guo WG, Wang C, Li ZH, Mao XJ, Yu B, Ma LY, Liu HM.
Wang B, et al. Among authors: zhao yd, zhao b.
Pharmacol Res. 2017 Aug;122:66-77. doi: 10.1016/j.phrs.2017.05.025. Epub 2017 May 30.
Pharmacol Res. 2017.
PMID: 28571892